Pfizer: News
24 May 2023
COVID-19COVID-19 still claims one life every four minutes
Weeks after the World Health Organization (WHO) declared COVID-19 not a health emergency anymore, thus officially marking the end of the pandemic that lasted for three years, the disease continues to kill one person every four minutes across the globe, Bloomberg reported.
13 Mar 2023
CancerPfizer acquires Seagen for $43 billion to improve cancer treatments
Pfizer has acquired Seagen, a Washington-based biotechnology company, for approximately $43 billion, in an attempt to expand its reach in cancer treatment. The pharmaceutical company is reported to have paid $229 per share.
25 Jan 2022
BioNTechPfizer, BioNTech begin clinical trial for Omicron-specific vaccine
Pfizer and BioNTech have begin the clinical trial for a vaccine against the Omicron variant of coronavirus, the companies said on Tuesday.
09 Dec 2021
World Health Organization'Cautious optimism' after initial Omicron studies; here's what we know
Early studies on the Omicron variant of coronavirus reportedly present a less grim picture than previously imagined.
03 Dec 2021
Serum Institute of IndiaCOVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective
Seven COVID-19 vaccines are safe and stimulate a strong immune response when used as a booster jab to those who have already vaccinated, a study published in The Lancet said.
17 Nov 2021
CoronavirusCOVID-19: India reports 10K+ infections; 301 more deaths
India on Wednesday reported over 10,000 new COVID-19 cases with an active caseload of 1.28 lakh, the lowest in 527 days.
11 Nov 2021
United States of AmericaIndia may approve anti-COVID-19 drug molnupiravir soon: Report
India is reportedly likely to approve Merck's anti-COVID-19 drug molnupiravir soon.
05 Nov 2021
CoronavirusPfizer pill cuts risk of severe COVID-19 by 89%
American company Pfizer's experimental antiviral pill to treat COVID-19 cuts the risk of hospitalization and death by 89% in vulnerable adults, according to clinical trial results.
02 Oct 2021
Health & WellnessHere are some key drugs being tested for COVID-19 treatment
Several antiviral drugs are being developed and tested for COVID-19 treatment as scientists around the world race to find new methods to fight the pandemic and ease the burden on hospitals.
29 Sep 2021
COVID-19Pfizer is testing new anti-COVID-19 pill. How does it work?
Biopharmaceutical company Pfizer on Monday said that it has started middle-to-late stage clinical trial of an anti-COVID-19 pill to tackle the disease.
22 Sep 2021
Sri LankaCOVID-19 vaccines: Sri Lanka seeks $100 million assistance from IMF
Sri Lanka has decided to ask for a $100 million loan from IMF to procure 14 million doses of Pfizer COVID-19 vaccine and finance other vaccination program-related costs, it was announced on Wednesday.
20 Sep 2021
United States of AmericaPfizer-BioNTech vaccine 'safe' for kids aged 5-11; generates 'robust immunity'
The COVID-19 vaccine developed by Pfizer and BioNTech has been found safe for children between five to 11 years of age and generates a "robust" immune response, the companies said on Monday.
14 Sep 2021
EnglandEngland school children aged 12-15yrs to be offered COVID-19 vaccine
School children aged between 12 and 15 years will be offered a first dose of the Pfizer/BioNTech COVID-19 vaccine starting next week, the UK government has announced after the country's Chief Medical Officers gave their go-ahead for the jabs for younger age groups.
13 Sep 2021
USACOVID-19 vaccines for younger kids could be available from October
Amid surging Delta variant cases in the USA, COVID-19 vaccines for children younger than 12 years could be available by the end of next month, a media report has said.
09 Sep 2021
ResearchNo serious vaccine side effects in breastfeeding moms, infants: Study
Breastfeeding mothers vaccinated with Pfizer or Moderna preventive experienced similar side effects to what have previously been reported in non-breastfeeding women, while infants exhibited no adverse events after immunization, a study has found.
06 Sep 2021
United States of America80% immunity from Pfizer vaccine lost in 6 months: Study
COVID-19 antibodies generated by the Pfizer vaccine dipped by more than 80% six months after the second dose, a study conducted in the United States has found.
23 Aug 2021
United States of AmericaUS: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA
The Pfizer-BioNTech COVID-19 vaccine has finally received full approval from the US Food and Drug Administration (FDA) on Monday for use in people aged 16 and above in the country.
21 Aug 2021
Joe BidenPfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week
The United States Food and Drug Administration (FDA) is reportedly set to grant full approval to Pfizer-BioNTech's two-dose COVID-19 vaccine next week, expediting the previous timeline for licensing the vaccine.
19 Aug 2021
CoronavirusPfizer, AstraZeneca vaccines less effective against Delta variant: Oxford study
COVID-19 vaccines developed by Pfizer and AstraZeneca are less effective against the Delta variant of the coronavirus, compared to the Alpha variant, a study led by researchers at the University of Oxford said.
20 Jul 2021
University Of CaliforniaNo sign of Pfizer, Moderna vaccines in breast milk: Study
Researchers have found no evidence of the presence of Pfizer or Moderna COVID-19 vaccines in breast milk suggesting that mRNA preventives are safe during lactation.
05 Jul 2021
COVID-19Pfizer COVID-19 vaccine induces good immune response against coronavirus variants
Two doses of the Pfizer COVID-19 vaccine induce a "very good" antibody response against the SARS-CoV-2 variants, according to a study on 180 health care workers in Finland.
02 Jul 2021
IndiaMix-and-match COVID-19 vaccines: What do studies say?
In most coronavirus vaccination regimes, two doses of the same brand are given a few weeks apart.
24 Jun 2021
AstraZenecaSingle dose of Pfizer, AstraZeneca vaccines offers 60 percent protection
A single dose of Pfizer or AstraZeneca COVID-19 vaccine offers around 60 percent protection against infection from SARS-CoV-2 in adults aged 65 years and above, according to a study published in The Lancet Infectious Diseases.
15 Jun 2021
CoronavirusPfizer, AstraZeneca vaccines protect against Delta variant, says study
Pfizer and AstraZeneca vaccines provide good protection against the Delta variant of coronavirus, first identified in India, says a study published in The Lancet Journal.
14 Jun 2021
IndiaHow does India plan to vaccinate children against coronavirus?
The Indian government wants to soon start inoculating children against the coronavirus. However, there is no vaccine for that group yet.
10 Jun 2021
Joe BidenUS will distribute 500M Pfizer vaccine doses to 100 countries
The United States is buying 500 million doses of the Pfizer coronavirus vaccine to donate them among nearly 100 countries by the next year, top American newspapers have reported.
04 Jun 2021
Vaccine'Benefits outweigh risks'; UK clears Pfizer vaccine for ages 12-15
The United Kingdom on Friday decided to approve the COVID-19 vaccine developed by Pfizer-BioNTech for use among those aged 12-15 years.
03 Jun 2021
Government of IndiaAfter Pfizer and Moderna, Serum seeks indemnity over COVID-19 vaccine
The Serum Institute of India has requested the Indian government to provide it indemnity from liability in connection with its COVID-19 vaccines, company sources cited by NDTV and The Hindu say.
03 Jun 2021
CoronavirusMost COVID-19 vaccines might offer lasting protection: Study
The world's leading COVID-19 vaccines, including the ones from Pfizer and Moderna, may offer lasting protection that diminishes the need for frequent booster shots.
02 Jun 2021
IsraelIsrael finds possible link between Pfizer vaccine and heart inflammation
Israel has flagged a possible link between the COVID-19 vaccine developed by Pfizer-BioNTech and cases of heart inflammation (myocarditis), observed mainly in young men.
02 Jun 2021
Government of IndiaForeign COVID-19 vaccines exempted from local trials, batch testing
The Drugs Controller General of India has scrapped the requirement of local trials for foreign-made coronavirus vaccines - a key move to upscale the dwindling COVID-19 vaccinations in the country.
27 May 2021
Arvind KejriwalIndia should procure Pfizer's COVID-19 vaccine for children: Kejriwal
Delhi Chief Minister Arvind Kejriwal on Thursday sought procurement of Pfizer COVID-19 vaccine as soon as possible to inoculate children.
27 May 2021
Government of IndiaPfizer's vaccine works against B.1.617 variant, firm tells Indian government
Pfizer has told the Indian government that its coronavirus vaccine shows "high effectiveness" on the COVID-19 variant prevalent in India as well as on people of Indian ethnicity or nationality.
25 May 2021
VaccineIndia may not receive Pfizer, Moderna vaccine doses until 2023
India may not receive doses of the COVID-19 vaccines developed by Pfizer and Moderna until 2023 as the manufacturers have other commitments.
24 May 2021
Arvind KejriwalPfizer, Moderna have refused to sell vaccines directly to Delhi
American pharmaceutical companies Pfizer and Moderna have said they would not sell their coronavirus vaccines directly to the Delhi government, Chief Minister Arvind Kejriwal revealed today.
21 May 2021
COVID-19Delayed second Pfizer shot boosts immunity by over three times
Delay in giving a second dose of the Pfizer COVID-19 vaccine by 12 weeks increases antibody response in older people by three-and-a-half times compared to those who receive it at a three-week interval, according to a study conducted in the UK.
15 May 2021
Indian GovernmentIndia may buy 50mn Pfizer COVID-19 vaccine doses: Details here
At a time when India is facing an acute shortage of COVID-19 vaccines, the Centre is in "high-level" discussions with American pharmaceutical giant Pfizer, which is likely to sell 50 million doses of its vaccine in India by the third quarter of this year.
14 May 2021
United States of AmericaAmericans can finally ditch the mask, says CDC
In the biggest indication that the United States is fast returning to pre-pandemic life, the Centers for Disease Control and Prevention (CDC) has said fully vaccinated people are no longer required to wear masks.
11 May 2021
VaccineAstraZeneca vaccine's single dose reduces death risk by 80%: Data
A single dose of AstraZeneca's COVID-19 vaccine results in an 80% less risk of death from the viral infection, Public Health England (PHE), the executive agency of the UK department of health, said on Monday, citing data from the vaccine's rollout.
11 May 2021
United States of AmericaUS expands Pfizer COVID-19 shot to children 12 and above
COVID-19 vaccines finally are headed for more kids as US regulators on Monday expanded the use of Pfizer's shot to those as young as 12, sparking a race to protect middle and high school students before they head back to class.